JNJ vs ELV
By Alex · Tickerpine
Johnson & Johnson vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ELV |
|---|---|---|
| Price | $254.66 | $395.18 |
| Market cap | $613.02B | $85.82B |
| P/E ratio | 29.5 | 16.8 |
| ROE | 26.42% | 12.09% |
| Profit margin | 21.83% | 2.62% |
| Revenue growth | 9.90% | 2.60% |
| Dividend yield | 2.10% | 1.74% |
| Beta | 0.26 | 0.68 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ELV in plain English
- JNJ is the bigger company — about 7.1× the market cap of ELV.
- ELV is cheaper on earnings (P/E 16.8 vs 29.5).
- JNJ earns a higher return on equity (26% vs 12%).
- JNJ is growing revenue faster (10% vs 3%).
- JNJ has the higher dividend yield (2.10% vs 1.74%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.